Recommended Protocol for the Study of the Ex Vivo Biological Effects of Virus-Inactivated Plasma Concentrates in Patients with von Willebrand Disease-Reference-Cited by-同舟云学术

Recommended Protocol for the Study of the Ex Vivo Biological Effects of Virus-Inactivated Plasma Concentrates in Patients with von Willebrand Disease

Published:1992 Issue:01 Volume:68 Page:084-087
ISSN:0340-6245
Container-title:Thrombosis and Haemostasis
language:en
Short-container-title:Thromb Haemost

Author:

Mannucci P M¹²

Affiliation:

1. The Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, Milan, Italy

2. On behalf of the von Willebrand Factor Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis and of the von Willebrand Disease Committee of the World Federation of Hemophilia

Publisher

Georg Thieme Verlag KG

Subject

Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0038-1656323.pdf

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease;Expert Opinion on Drug Safety;2009-03

2. Intravenous DDAVP and Factor VIII-von Willebrand Factor Concentrate for the Treatment and Prophylaxis of Bleedings in Patients With von Willebrand Disease Type 1, 2 and 3;Clinical and Applied Thrombosis/Hemostasis;2007-01

3. The 80th anniversary of von Willebrand's disease: history, management and research;Haemophilia;2006-11

4. Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods;Journal of Thrombosis and Haemostasis;2005-09-29

5. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys;Blood Coagulation & Fibrinolysis;2005-04